. Author manuscript; available in PMC: 2012 Nov 1.

Published in final edited form as: Toxicol Appl Pharmacol. 2011 Jun 12;256(3):258–267. doi: 10.1016/j.taap.2011.05.021

Table 3.

Quantification of amacrine cell populations in the inner nuclear layer (INL)

	Cell Counts	Control	Low Lead	Moderate Lead	High Lead
Wholemounts^a	TH (Dorsal)	16.5 ± 0.3	11.1 ± 0.7^*	9.4 ± 0.5^**	7.3 ± 0.6^**
	TH (Ventral)	17.3 ± 0.6	15.8 ± 0.3^*	12.7 ± 0.4^*	10.5 ± 0.3^**
	ChAT (Dorsal)	367 ± 16	371 ± 19	375 ± 21	359 ± 24
	ChAT (Ventral)	372 ± 19	368 ± 22	368 ± 25	363 ± 18
Vertical Sections^b	ChAT	16 ± 3	17 ± 4	17 ± 3	16 ± 4
	Dab1	17 ± 3	16 ± 4	15 ± 5	17 ± 4
	GABA	7 ± 1	8 ± 1	7 ± 1	8 ± 2

TH: Tyrosine hydroxylase; IR: Immunoreactive; ChAT: Choline acetyltransferase; Dab1: Disabled1

Values represent the mean ± SEM for 500 µm² of dorsal or ventral retina from three to nine different whole mounted mouse retinas per treatment group.

Values represent the means ± SEM for 40 µm fixed-frozen transverse sections from three non-adjacent slides for three to five different mouse retinas per treatment group.

p< 0.05 and

^**

p<0.01 compared with corresponding controls.